![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Asia Pacific Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)
Market Introduction
APAC is the fastest-growing regional market for immunohistochemistry; and China, India, Japan, South Korea, Australia, and Rest of APAC are the major contributors to the market in this region. China led the market in 2021. The market's growth is attributed to the increasing R&D activities, rising investments in the healthcare sector in developing countries, and increasing collaborations between regulatory outsourcing and drug developers. The market players are launching products. For instance, in August 2020, Gilead Sciences Inc. received approval for Truvada, an HIV prevention for use in adults and adolescents medicine in China. This approval will help in preventing HIV among the healthy population. Numerous infectious diseases are emerging, re-emerging, or causing recurrent outbreaks in Asia and the Pacific region. People traveling more frequently, living in more densely populated areas, and coming into closer contact with wild animals, have increased the potential for emerging infectious diseases to spread rapidly. The current COVID-19 situation has also increased the surveillance of the influenza virus among the population to improve the diagnosis of the disease. According to the National Health Commission (NHC) of China, there were a total of 81,285 coronavirus-infected cases reported in China by March 26th, 2020, with a total number of 3,287 deaths due to the virus outbreak. The disease was transmitted at a rapid pace in the initial phases. However, the prevalence of diseases due to different viral infections such as the Rotavirus viral, Hepatitis A-E virus, Dengue virus, and others are also expected to drive the market in the forecast period. This, rising remerging infectious diseases, improving diagnostic capabilities, and rise in government programs regarding the better understanding of viral diseases are expected to drive Immunohistochemistry market growth in coming years.
Countries in APAC, especially India, are highly affected due to the COVID-19 outbreak. The supply chain disturbances and the tremendous demand for efficient treatments for the therapy of COVID-19 have put the healthcare research industry in a crucial situation in APAC. Prohibitive measures have been taken to control the spread of the novel coronavirus. The COVID-19 pandemic has adversely affected economies in the region. The socioeconomics was severely affected, rising in negative inflation, GDPs, and a regional unemployment surge. Countries, such as China, Japan, Singapore, and South Korea, are seeing an increased interest in clinical trials. High costs in western countries are also contributing to the flow of medical affairs outsourcing to APAC. To expand sales to the Asian market, pharmaceutical companies are becoming aware of new and changing regulatory environments for drugs, devices, and in-vitro diagnostics. New or improved regulations are implemented frequently in Asia, including changes in GMP standards, drug price controls, and medical device regulatory systems. Third-party guidance and advice are required as a part of any acquisition or any improvement of current standards. Increasingly, third-party outsourcing service providers are playing a significant role in supporting the associated market in APAC. However, the market has stabilized compared to the initial phases of the pandemic owing to the control procedures, awareness among people, vaccination availability, and supportive government policies of the business in the related market.
![](https://www.theinsightpartners.com//assets/rdimages/25464-img1.png)
Get more information on this report :
Market Overview and Dynamics
The APAC immunohistochemistry market is expected to grow from US$ 483.76 million in 2021 to US$ 818.00 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibody for tissue determination and distribution of antigens of particular disease. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases. Diabetes is prevailing at a high rate in the geriatric population across the region. The prevalence of diabetes is more in overweight and obese people. The obesity rates have been increasing rapidly in developed as well as developing economies across the region. Factors such as unhealthy lifestyle and sedentary life are among the major for the rise in the number of obese individuals. Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality across the region. Furthermore, there has been a rise in cancer incidence and mortality rates all over the region, making cancer the leading cause of death. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the APAC region.
Key Market Segments
In terms of product, the antibodies segment accounted for the largest share of the APAC immunohistochemistry market in 2020. In terms of application, the diagnostics segment held a larger market share of the APAC immunohistochemistry market in 2020. Further, the hospitals and diagnostic laboratories segment held a larger share of the APAC immunohistochemistry market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the APAC immunohistochemistry market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORIES INC.; Cell Signaling Technology, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; and THERMO FISHER SCIENTIFIC INC.
Reasons to buy report
- To understand the APAC immunohistochemistry market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC immunohistochemistry market
- Efficiently plan M&A and partnership deals in APAC immunohistochemistry market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC immunohistochemistry market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC Immunohistochemistry Market Segmentation
APAC Immunohistochemistry Market - By Product
- Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
APAC Immunohistochemistry Market - By Application
- Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Others
- Drug Testing
APAC Immunohistochemistry Market - By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
APAC Immunohistochemistry Market - By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
APAC Immunohistochemistry Market - Company Profiles
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Immunohistochemistry Market – By Product
1.3.2 APAC Immunohistochemistry Market – By Application
1.3.3 APAC Immunohistochemistry Market – By End User
1.3.4 APAC Immunohistochemistry Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Escalating Incidences of Chronic and Infectious Diseases
5.1.2 Surging R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Complications Related to Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Burgeoning Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Growing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – APAC Analysis
6.1 APAC Immunohistochemistry Market Revenue Forecast and Analysis
7. APAC Immunohistochemistry Market Analysis– By Product
7.1 Overview
7.2 APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8. APAC Immunohistochemistry Market Analysis – By Application
8.1 Overview
8.2 APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC Immunohistochemistry Market Analysis– By End User
9.1 Overview
9.2 APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10. APAC Immunohistochemistry Market – Country Analysis
10.1 APAC Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 Overview
10.1.2 APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.2.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.2.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.2.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.2.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.2.3 India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.2.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.2.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.2.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.2.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.2.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.2.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.2.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.2.6 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.2.6.2.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.2.6.2.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
10.1.2.6.2.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.2.6.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.1.2.6.3.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.2.6.4 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic developments
12.3.1 Overview
13. Company Profiles
13.1 Cell Signaling Technology, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abcam plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BIO-RAD LABORATORIES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio SB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 4. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 5. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 8. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 11. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 12. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 15. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 18. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 19. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 22. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 24. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 25. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 26. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 27. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 28. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 29. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 30. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 31. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 32. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 33. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 34. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 35. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 36. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 37. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)
Table 38. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 39. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 40. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 41. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 42. Organic Developments Done By Companies
Table 43. Inorganic developments done by Companies
Table 44. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Immunohistochemistry Market Segmentation
Figure 2. APAC Immunohistochemistry Market Segmentation, By Country
Figure 3. APAC Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market
Figure 8. APAC Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9. APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10. APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30. APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38. APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39. APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. APAC Immunohistochemistry Market Overview, by Country (2021)
Figure 43. APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Impact of COVID-19 Pandemic in APAC Country Markets
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution